29 projects

Date from new to old

UTVIKLING-UTVIKLING

Norwegian Research School in Global Health for Sustainable Futures

In the efforts to achieve the United Nations Sustainable Development Goals (SDGs), it is crucial that Norway enhances its broad competence in global health research, including by advancing research into interventions and global health initiatives that Norway support through its development cooper...

Awarded: NOK 16.0 mill.

Project Period: 2025-2033

Location: Vestland

UTVIKLING-UTVIKLING

An international collaboration on adolescent's health situation in Zambia, Tanzania and Norway.

The partners of the present pre-project want to enhance knowledge and build capacity in youth health across all three partner institutions. This will be done by a) disseminating of updated knowledge on adolescent's physical, mental, and social health through 2 PhD projects based on data collected...

Awarded: NOK 0.28 mill.

Project Period: 2024-2025

Location: Troms - Romsa - Tromssa

UTVIKLING-UTVIKLING

Establishing sustainable partnerships for preventing childhood lead poisoning in Viet Nam

Lead exposure is a critical global health issue impacting about one-third of children globally, with Southeast Asia with Southeast Asia facing the greatest burden. Despite this, research in many low- and middle-income countries, including Vietnam, is sparse. In May 2024, UNICEF and the US Agency ...

Awarded: NOK 0.30 mill.

Project Period: 2024-2025

Location: Troms - Romsa - Tromssa

UTVIKLING-UTVIKLING

Strengthening Climate-Health Alliances: Equitable Partnerships for Heat Adaptation Interventions in Africa

Despite the growing need for heat adaptation solutions to limit adverse health impacts, implementation in LLMICs remains limited and research fragmented. Increased implementation requires knowledge of effective, relevant, mature, and feasible measures, and of possible local barriers and solutions...

Awarded: NOK 0.30 mill.

Project Period: 2024-2025

Location: Oslo - Oslove

UTVIKLING-UTVIKLING

Mitigating Health Risks of Climate Change through Sustainable Forest Restoration in Africa

The pre-project aims to foster equitable collaboration with new research partners from low- and lower-middle-income countries (LLMICs) and local user partners. This involves forming a transdisciplinary consortium and further developing the proposal for the Collaborative and Knowledge-building Glo...

Awarded: NOK 0.30 mill.

Project Period: 2024-2025

Location: Oslo - Oslove

UTVIKLING-UTVIKLING

"Pre-HIRM"- Health outcomes among internally displaced persons (IDPs) and refugees in conflict-affected areas of Myanmar post-military coup

The main HIRM project aims to address the health disparities among internally displaced Persons (IDPs) and refugees worsen by Myanmar's ongoing conflicts and political instability. This pre-project HIRM is preparing for a major application focused on sustainable health interventions, aiming for t...

Awarded: NOK 0.30 mill.

Project Period: 2024-2026

Location: Troms - Romsa - Tromssa

UTVIKLING-UTVIKLING

Emollient therapy for very low birthweight infants (<1500g) in Uganda: effects on survival, infection, growth and development

Imagine this: Every year, 15 million babies are born "too soon," or preterm, and more than 70% of them are born in places like sub-Saharan Africa and South Asia. These tiny tots face a big problem – being born too early is a major cause of death for children under 5 years old all around the world...

Awarded: NOK 12.0 mill.

Project Period: 2024-2028

Location: Vestland

UTVIKLING-UTVIKLING

Implementing a life course approach in antenatal and postnatal care settings for prevention and reduction of non-communicable disease risks

The global increase in non-communicable diseases (NCDs), primarily diabetes, cardiovascular disease, cancer, respiratory disease and mental health disorders, places a high burden on both individuals and societies, including health systems. It affects quality of life, education, and workforce prod...

Awarded: NOK 10.0 mill.

Project Period: 2023-2028

Location: Oslo - Oslove

NYSKAPNING-NYSKAPNING

Biomarker for personalized therapy of breast cancer by de-escalating adjuvant chemotherapy

Scientists from OUS and UiO have identified a unique biomarker in patients with basal-like breast cancer, which indicates a favorable prognosis. Most of these patients have triple-negative breast cancer. Currently, the majority of these patients undergo chemotherapy before or after surgery. This ...

Awarded: NOK 0.49 mill.

Project Period: 2023-2025

Location: Oslo - Oslove

UTVIKLING-UTVIKLING

Toxic exposures in early life, growth, and development: An exposome study in Nepal.

The aim of this project is to identify environmental contaminants in pregnant women and infants in Nepal. Within an exposome framework, we will investigate the associations between these contaminants and child health and development. We analyzed trace elements and heavy metals in 799 samples coll...

Awarded: NOK 12.0 mill.

Project Period: 2023-2027

Location: Vestland

UTVIKLING-UTVIKLING

PRESHA Project - PREventing Severe Hypertensive Adverse events in pregnancy and childbirth

Globally 76 000 women and 500 000 infants die each year due to Preeclampsia (PE). Early identification of women at risk and timely prevention and treatment of PE will greatly reduce maternal and perinatal death and disability, a core priority in the Sustainable Development Goals. Global guideline...

Awarded: NOK 12.0 mill.

Project Period: 2023-2028

Location: Oslo - Oslove

UTVIKLING-UTVIKLING

Pesticides and exposures from traditional textile industry associated with own and offspring health in indigenous Guatemalan communities

Harmful work environments are a global challenge, most prominent in low-income settings. New science suggests toxic exposures may affect germ cells, and thereby health and disease in future offspring. If true, radical rethinking of preventive strategies is needed - can also offspring benefit from...

Awarded: NOK 12.0 mill.

Project Period: 2023-2028

Location: Vestland

UTVIKLING-UTVIKLING

Randomised controlled trial in Nepal: Implementing point-of-care tests and identifying barriers to reduce antibiotics for vaginal discharge

Abnormal vaginal discharge is a common symptom of vaginal or sexually transmitted infections (STIs). In low-income countries, diagnostic laboratory tests are not readily accessible and women may receive several types of antibiotics for abnormal vaginal discharge to cover a range of potential STIs...

Awarded: NOK 6.9 mill.

Project Period: 2023-2027

Location: Trøndelag - Trööndelage

FORSKNINGSINFRA-FORSKNINGSINFRA

Biobank Norway 4 - a national biobank research infrastructure

As a national research infrastructure, Biobank Norway (BN1 2011-15, BN2 2016-20, BN3 2020-24) has been instrumental in the establishment of a modern, advanced and comprehensive nationwide biobank network at all partner institutions and has fulfilled a primary objective of promoting outstanding re...

Awarded: NOK 100.0 mill.

Project Period: 2022-2031

Location: Trøndelag - Trööndelage

FRIHUMSAM-Fri prosjektstøtte for hum.fag og samfunnsvitenskap

EUI - 4. år - Natural Disasters: Demographic and Health Outcomes for Women and Children

...

Awarded: NOK 0.25 mill.

Project Period: 2021-2022

Location: Ukjent Fylke

UTVIKLING-UTVIKLING

Evidence-based policies and health systems interventions for antenatal care

In the district of Mukono, Uganda, 30,000 women give birth every year. Among them, about 130 die during pregnancy, childbirth, or within 42 days of delivery, and about 1400 experience that their baby dies after 28 weeks of pregnancy or during the first week of life. Mukono has 57 public health fa...

Awarded: NOK 12.0 mill.

Project Period: 2021-2026

Location: Oslo - Oslove

UTVIKLING-UTVIKLING

Reporting in context: An interdisciplinary initiative to strengthen maternal health services and surveillance in Ethiopia and Tanzania

In the last 10 years, a number of measures have been introduced to reduce persistently high maternal mortality globally. Nevertheless, an estimated 300,000 women lose their lives in pregnancy and childbirth each year. The WHO's Maternal Death Surveillance and Response System (MDSR) is a tool for ...

Awarded: NOK 12.3 mill.

Project Period: 2021-2026

Location: Vestland

UTVIKLING-UTVIKLING

Equity and financial household impact in randomised controlled trials, implementation research and cohort studies in India (EQUIFINANCE)

As countries work toward achieving the Sustainable Development Goals, it is essential to ensure equitable access to healthcare services and to prevent people from falling into poverty due to healthcare expenditures. The EquiFinance project, supported by the Research Council of Norway, investigate...

Awarded: NOK 12.0 mill.

Project Period: 2021-2026

Location: Vestland

UTVIKLING-UTVIKLING

Covid-19 and the Kenyan health system: a collaborative ethnographic study

In May 2023, the WHO declared an end to the global public health emergency for Covid-19, more than three years after the WHO declared COVID-19 to be a pandemic. Covid-19 remains a public health threat, and is still highly infectious, but death rates decreased, and the pressure on once-overwhelmed...

Awarded: NOK 12.0 mill.

Project Period: 2021-2026

Location: Oslo - Oslove

HELSEVEL-H-Gode og effektive helse-, omsorgs- og velferdstjenester

Organizing an international global health congress- 12th European Congress on Tropical Medicine and International Health (ECTMIH) 2021

This application concerns support for organizing an international global health congress- the 12th European Congress on Tropical Medicine and International Health (ECTMIH) 2021 in Bergen 28/9-1/10 2021. The congress plan for 1000 participants; scientists, practitioners, students, policy makers. T...

Awarded: NOK 0.30 mill.

Project Period: 2021-2021

Location: Vestland

GLOBVAC-Global helse- og vaksinasjonsforskn.

SARS-CoV-2 infection and COVID-19 in women and their infants in Kampala, Uganda

Uganda's first confirmed COVID-19 case was identified on the 22nd of March, 2020, and by the end of 2022, somewhat more than 170,000 cases had been confirmed with an estimated 3600 deaths (https://coronavirus.jhu.edu/map.html), most of them among people with known risk factors for severe COVID-19...

Awarded: NOK 5.0 mill.

Project Period: 2020-2023

Location: Vestland

GLOBVAC-Global helse- og vaksinasjonsforskn.

Climate Heat And Maternal and Neonatal Health in Africa

The CHAMNHA project contains four work packages (WPs) related to climate change and maternal/newborn health. In epidemiological studies (WP 1), we analysed pre-existing datasets of daily activities in women after birth in Burkina Faso. We found a relation between extreme temperatures and a reduc...

Awarded: NOK 3.6 mill.

Project Period: 2020-2024

Location: Oslo - Oslove

UTVIKLING-UTVIKLING

An effectiveness trial (phase IV) to evaluate protection of children and pregnant women by influenza vaccine in rural Bangladesh

Annually influenza is a leading cause of severe disease and mortality particularly in young children less than 5 years old and pregnant women in the low and middle-income countries (LMICs) and both groups are prioritised for vaccination by the World Health Organisation (WHO). In Bangladesh, influ...

Awarded: NOK 16.9 mill.

Project Period: 2019-2026

Location: Vestland

UTVIKLING-UTVIKLING

Pragmatic Trial for HIV Pre-Exposure Prophylaxis Roll-Out in Tanzania

During the past decade, the proportion of people infected with HIV in the general population in Tanzania decreased by half (from 8.3% to 4.7%). However, the proportion of men who have sex with men (MSM) and female sex workers (FSW) living with HIV is almost 5 times higher. Preventive use of antir...

Awarded: NOK 15.2 mill.

Project Period: 2019-2025

Location: Oslo - Oslove

GLOBVAC-Global helse- og vaksinasjonsforskn.

Enabling sustainable public engagement in improving health and health equity

Claims about what people should or should not do for their health are everywhere. To make well-informed decisions, people must be able to think critically about what claims to believe and what to do. It is important that teenagers learn to think critically about health and make informed choices. ...

Awarded: NOK 14.9 mill.

Project Period: 2019-2024

Location: Oslo - Oslove

GLOBVAC-Global helse- og vaksinasjonsforskn.

Developing HIV broadly neutralising antibodies as a prevention product for global access through antibody half-life extension engineering.

Almost 2 million people are infected with HIV annually and up to 30% are young women and teenage girls in sub-Saharan Africa. In addition, India is one of the countries with the largest ongoing HIV epidemic. Until a vaccine is developed, no single product will be able to prevent new HIV infection...

Awarded: NOK 19.1 mill.

Project Period: 2019-2024

Location: Oslo - Oslove

GLOBVAC-Global helse- og vaksinasjonsforskn.

Dihydroartemisinin-Piperaquine for the Chemoprevention of Malaria in Children with Sickle Cell Anaemia in eastern and southern Africa

Sickle Cell Anaemia (SCA) is one of the most common inherited disorders in the world. The disorder causes complications and substantial morbidity and death in children under five in sub-Saharan Africa. Malaria remains widespread and is a major cause of morbidity and mortality. Children with SCA h...

Awarded: NOK 20.0 mill.

Project Period: 2019-2024

Location: Vestland

UTVIKLING-UTVIKLING

TREAT Child Alcohol Use Disorder (C-AUD) in Eastern Uganda: Screening, diagnostics, risk factors and handling of children drinking alcohol

Alcoholic beverages have both cultural and social dimensions, yet alcohol use can also affect mental and physical health, impair social functioning, lead to dependence, and cause harm (alcohol use disorder, AUD). Early and pronounced substance use in childhood increases the likelihood of problems...

Awarded: NOK 15.5 mill.

Project Period: 2019-2026

Location: Vestland

GLOBVAC-Global helse- og vaksinasjonsforskn.

School and community-based student-driven dengue vector control and monitoring in Myanmar: A cluster randomized controlled trial

Dengue is the most common and widespread mosquito-borne arboviral disease globally, causing more than 390 million infections and more than 20,000 deaths annually. There are no effective vaccines, preventive drugs or treatments. Therefore, current efforts to reduce dengue transmission rely primari...

Awarded: NOK 9.5 mill.

Project Period: 2019-2024

Location: Akershus